We are live on
!
Find out more
Dianthus Therapeutics
DNTH
DNTH
91 hedge funds and large institutions have $859M invested in Dianthus Therapeutics in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 6
60% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 20
23% more funds holding
Funds holding: 74 → 91 (+17)
12% more capital invested
Capital invested by funds: $769M → $859M (+$89.9M)
5.66% more ownership
Funds ownership: 101.2% → 106.86% (+5.7%)
0% more call options, than puts
Call options by funds: $11K | Put options by funds: $11K
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
91
Holders Change
+17
Holders Change %
+22.97%
% of All Funds
1.31%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.07%
New
24
Increased
32
Reduced
20
Closed
6
Calls
$11K
Puts
$11K
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$13.5M |
| 2 |
VA
VR Adviser
New York
|
-$9.75M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.47M |
| 4 |
VPC
Vestal Point Capital
New York
|
-$5.71M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$1.73M |
